Search

everythinglearnresearchcommunity

for

Search:↓

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

The document cannot be parsed.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

High doses of TCB cause severe health issues in marmoset monkeys.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Cepharanthine shows promise as a natural anticancer treatment.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Phaeodactylum tricornutum extract helps hair follicle cells grow by activating the ERK1/2 pathway.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

CTE can distort results in hair growth trials, so exclude it carefully.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Tislelizumab can cause cutaneous lupus erythematosus.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.